Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Am J Phys Med Rehabil ; 100(12): 1115-1123, 2021 12 01.
Artigo em Inglês | MEDLINE | ID: mdl-34793372

RESUMO

OBJECTIVE: The aim of the study was to present: (1) physiatric care delivery amid the SARS-CoV-2 pandemic, (2) challenges, (3) data from the first cohort of post-COVID-19 inpatient rehabilitation facility patients, and (4) lessons learned by a research consortium of New York and New Jersey rehabilitation institutions. DESIGN: For this clinical descriptive retrospective study, data were extracted from post-COVID-19 patient records treated at a research consortium of New York and New Jersey rehabilitation inpatient rehabilitation facilities (May 1-June 30, 2020) to characterize admission criteria, physical space, precautions, bed numbers, staffing, employee wellness, leadership, and family communication. For comparison, data from the Uniform Data System and eRehabData databases were analyzed. The research consortium of New York and New Jersey rehabilitation members discussed experiences and lessons learned. RESULTS: The COVID-19 patients (N = 320) were treated during the study period. Most patients were male, average age of 61.9 yrs, and 40.9% were White. The average acute care length of stay before inpatient rehabilitation facility admission was 24.5 days; mean length of stay at inpatient rehabilitation facilities was 15.2 days. The rehabilitation research consortium of New York and New Jersey rehabilitation institutions reported a greater proportion of COVID-19 patients discharged to home compared with prepandemic data. Some institutions reported higher changes in functional scores during rehabilitation admission, compared with prepandemic data. CONCLUSIONS: The COVID-19 pandemic acutely affected patient care and overall institutional operations. The research consortium of New York and New Jersey rehabilitation institutions responded dynamically to bed expansions/contractions, staff deployment, and innovations that facilitated safe and effective patient care.


Assuntos
COVID-19/reabilitação , Utilização de Instalações e Serviços/estatística & dados numéricos , Necessidades e Demandas de Serviços de Saúde/estatística & dados numéricos , Pacientes Internados/estatística & dados numéricos , Cuidados Semi-Intensivos/estatística & dados numéricos , Doença Aguda , Cuidados Críticos/estatística & dados numéricos , Bases de Dados Factuais , Feminino , Estado Funcional , Humanos , Tempo de Internação/estatística & dados numéricos , Masculino , Pessoa de Meia-Idade , New Jersey , New York , Alta do Paciente/estatística & dados numéricos , Estudos Retrospectivos , SARS-CoV-2 , Cuidados Semi-Intensivos/métodos , Resultado do Tratamento
2.
Basic Res Cardiol ; 102(1): 28-41, 2007 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-17006633

RESUMO

Echocardiography is an essential diagnostic tool for accurate noninvasive assessment of cardiac structure and function in vivo. However, the use of anesthetic agents during echocardiographic studies is associated with alterations in cardiac anatomical and functional parameters. We sought to systematically compare the effects of three commonly used anesthetic agents on echocardiographic measurements of left ventricular (LV) systolic and diastolic function, LV dimensions, and LV mass in rats. Adult male Fischer 344 rats underwent echocardiographic studies under pentobarbital (PB, 25 mg/kg i.p.) (group I, n = 25), inhaled isoflurane (ISF, 1.5%) (group II, n = 25),or ketamine/xylazine (K/X, 37 mg/kg ketamine and 7 mg/kg xylazine i.p.) (group III, n = 25) anesthesia in a cross-over design. Echocardiography was also performed in an additional group of unanesthetized conscious rats (group IV, n = 5). Postmortem studies were performed to validate echocardiographic assessment of LV dimension and mass. Rats in group I exhibited significantly higher LV ejection fraction, fractional shortening, fractional area change, velocity of circumferential fiber shortening corrected for heart rate, and heart rate as compared with groups II and III. LV end-diastolic volume, end-diastolic diameter, and cross-sectional area in diastole were significantly smaller in group I compared with groups II and III. Cardiac output was significantly lower in group III compared with groups I and II. Postmortem LV mass measurements correlated well with echocardiographic estimation of LV mass for all anesthetic agents, and the correlation was best with PB anesthesia. Limited echocardiographic data obtained in conscious rats were similar to those obtained under PB anesthesia. We conclude that compared with ISF and K/X anesthesia, PB anesthesia at a lower dose yields echocardiographic LV structural and functional data similar to those obtained in conscious rats. In addition, PB anesthesia also facilitates more accurate estimation of LV mass.


Assuntos
Anestésicos Gerais/farmacologia , Ecocardiografia Doppler/efeitos dos fármacos , Coração/efeitos dos fármacos , Função Ventricular Esquerda/efeitos dos fármacos , Animais , Temperatura Corporal/efeitos dos fármacos , Peso Corporal/efeitos dos fármacos , Diástole/efeitos dos fármacos , Coração/anatomia & histologia , Frequência Cardíaca/efeitos dos fármacos , Ventrículos do Coração/anatomia & histologia , Ventrículos do Coração/efeitos dos fármacos , Hipnóticos e Sedativos/farmacologia , Isoflurano/farmacologia , Ketamina/farmacologia , Masculino , Tamanho do Órgão/efeitos dos fármacos , Fenobarbital/farmacologia , Ratos , Ratos Endogâmicos F344 , Sístole/efeitos dos fármacos , Xilazina/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA